BA
RGEN icon

Bridgewater Associates’s Repligen RGEN Stock Holding History

Bridgewater Associates’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,874
Closed -$1.29M – 1183
2025
Q4 		$1.29M Sell
7,874
-25,742
-77% -$4.03M ﹤0.01% 845
2025
Q3 		$4.49M Buy
+33,616
New +$4.08M 0.02% 514
2023
Q1 		– Sell
-6,898
Closed -$1.17M – 862
2022
Q4 		$1.17M Buy
6,898
+4,674
+210% +$848K 0.01% 625
2022
Q3 		$416K Sell
2,224
-1,386
-38% -$292K ﹤0.01% 795
2022
Q2 		$586K Buy
3,610
+618
+21% +$97.7K ﹤0.01% 883
2022
Q1 		$563K Buy
+2,992
New +$568K ﹤0.01% 873
2021
Q4 		– Sell
-736
Closed -$213K – 797
2021
Q3 		$213K Buy
+736
New +$189K ﹤0.01% 673

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bridgewater Associates's RGEN Position: Q1 2026 in Review

Bridgewater Associates sold out of Repligen (RGEN) in Q1 2026, closing a stake of 7,874 shares — an estimated $1.29M sold.

Bridgewater Associates first reported a position in RGEN in Q3 2021 and held it in 7 quarters. The position peaked at $4.49M in Q3 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Bridgewater Associates reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Bridgewater Associates sold 7,874 Repligen shares in Q1 2026, an estimated $1.29M.
  • Bridgewater Associates first reported a position in Repligen in Q3 2021 and held it in 7 quarters.
  • Bridgewater Associates's Repligen position peaked at $4.49M in Q3 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.